What is CAGE Code 4GBX7?

4GBX7 is the unique identifier used by NATO Organizations to reference the physical entity known as Biocryst Pharmaceuticals Inc located at 4505 Emperor Blvd Ste 200, Durham NC 27703-8457, United States.

Who is CAGE Code 4GBX7?

4GBX7 refers to Biocryst Pharmaceuticals Inc located at 4505 Emperor Blvd Ste 200, Durham NC 27703-8457, United States.

Where is CAGE Code 4GBX7 Located?

CAGE Code 4GBX7 is located in Durham, NC, USA.

How Many NSNs Does CAGE Code 4GBX7 Supply?

CAGE Code 4GBX7 has been assigned as an approved source for 1 NSNs (National Stock Numbers and NATO Stock Numbers).

Biocryst Pharmaceuticals Inc

CAGE Code: 4GBX7

NCAGE Code: 4GBX7

Status: Active

Type: Commercial Supplier

Dun & Bradstreet (DUNS): 618194609

Summary

Biocryst Pharmaceuticals Inc is an Active Commercial Supplier with the Cage Code 4GBX7 and is tracked by Dun & Bradstreet under DUNS Number 618194609..

Address

4505 Emperor Blvd Ste 200
Durham NC 27703-8457
United States

Points of Contact

No Points of Contact...

Related Information

DUNS Report

People who viewed this 'CAGE Code' also viewed...

Frequently Asked Questions (FAQ) for CAGE 4GBX7

What is CAGE Code 4GBX7?: 4GBX7 is the unique identifier used by NATO Organizations to reference the physical entity known as Biocryst Pharmaceuticals Inc located at 4505 Emperor Blvd Ste 200, Durham NC 27703-8457, United States.
Who is CAGE Code 4GBX7?: 4GBX7 refers to Biocryst Pharmaceuticals Inc located at 4505 Emperor Blvd Ste 200, Durham NC 27703-8457, United States.
Where is CAGE Code 4GBX7 Located?: CAGE Code 4GBX7 is located in Durham, NC, USA.
How Many NSNs Does CAGE Code 4GBX7 Supply?: CAGE Code 4GBX7 has been assigned as an approved source for 1 NSNs (National Stock Numbers and NATO Stock Numbers).

Contracting History for CAGE 4GBX7 Most Recent 25 Records

36C26023F0144
Berotralstat
19 Sep 2023: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $56,670.76
36C26023F0144
Berotralstat
20 Jan 2023: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $340,322.40
36C26022F0215
Berotralstat Hcl 150Mg Cap,Oral Bulk, 72769-0101-01
14 Sep 2023: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $113,440.80
36C26022F0215
Berotralstat Hcl 150Mg Cap,Oral Bulk, 72769-0101-01
20 May 2022: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $368,682.60
36F79721D0166
Pharmaceuticals
16 Nov 2023: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
Administration Change (Poc)
28 Oct 2021: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
Public Law 2022
2 Dec 2021: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
Admin / New Iff Sales Contact
14 Oct 2021: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
Administration Change (Poc)
25 Jul 2023: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
Administration Change (Fss Sales
27 Oct 2023: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
Public Law 2023
12 Dec 2022: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
36F79721D0166
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, Fss Contract Award
5 May 2021: Nac Federal Supply Schedule (36F797); Department Of Veterans Affairs (Va); $0.00
75N93020C00055
Option One Changed To Multiple Options By Mutual Agreement.
9 Oct 2020: National Institutes Of Health Niaid; Department Of Health And Human Services (Hhs); $6,326,480.00
75N93020C00055
Extend Period Of Performance For The Base Till September 30, 2022. (Note: The Modification P00003 Is Modification P00002 In The Nbs System, Modification P00004 Is Modification P00003 In The Nbs System And These Are Clarifications For Audit Purposes
29 Mar 2022: National Institutes Of Health Niaid; Department Of Health And Human Services (Hhs); $6,326,480.00
75N93020C00055
Covid-19. To Manufacture And Evaluate The Safety, Efficacy And Tolerability Of Galidesivir A Broad Spectrum, Antiviral Therapeutic.
31 Aug 2020: National Institutes Of Health Niaid; Department Of Health And Human Services (Hhs); $6,326,480.00
75N93020C00055
Revise Article I.3. By Adding Far Clause 52.223-99, Ensuring Adequate Covid-19 Safety Protocols For Federal Contractors (Oct 2021) (Deviation) And Extend Service Till Extend Period Of Performance Till March 31, 2022.
23 Jun 2021: National Institutes Of Health Niaid; Department Of Health And Human Services (Hhs); $6,326,480.00
HHSO100201500007C
Udo De-Obligation Of Expiring Fy 2015 Funding Biocryst Pharmaceuticals
29 Sep 2020: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $20,499,491.03
75D30118C02984
Peramivir, Rapivab Flu Treatment
1 Sep 2020: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $20,796,000.00
36E79721A0009
Bpa For Rapivab
8 Mar 2021: Nac Pharmaceuticals (36E797); Department Of Veterans Affairs (Va); $0.00
36C26022F0188
Berotralstat (Orladeyo) 150Mg
8 Mar 2022: 260-Network Contract Office 20 (36C260); Department Of Veterans Affairs (Va); $85,080.60
HHSN272201300017C
Biocryst; Development Of Therapeutic Medical Countermeasures For Biodefense And Emerging Infectious Diseases
11 Aug 2020: National Institutes Of Health Niaid; Department Of Health And Human Services (Hhs); $45,931,229.00
36E79721A0015
Exercise Option Year 1.
14 Apr 2022: Nac Pharmaceuticals (36E797); Department Of Veterans Affairs (Va); $0.00
HHSN272201300017C
Biocryst; Development Of Therapeutic Medical Countermeasures For Biodefense And Emerging Infectious Diseases
15 Sep 2021: National Institutes Of Health Niaid; Department Of Health And Human Services (Hhs); $47,314,895.00
75D30118C02984
Peramivir, Rapivab Flu Treatment
26 Aug 2021: Barda - Aspr / Daappo / Barda Dcma; Department Of Health And Human Services (Hhs); $27,728,000.00
75D30118C02984
Peramivir, Rapivab Flu Treatment
1 Oct 2018: Office Of Acq Mgmt Policy; Department Of Health And Human Services (Hhs); $6,932,000.00